ClinicalTrials.Veeva

Menu

The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients

Clalit Health Services logo

Clalit Health Services

Status

Completed

Conditions

Pressure Sores
Intensive Care

Treatments

Dietary Supplement: Eicosapentanoic acid, docosahexaenoic acid

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to investigate whether the addition of omega-3 and antioxidants to nutritional support in critically ill patients in the intensive care unit influences the immune and anti-inflammatory systems and so improves wound healing.

Full description

A prospective randomized study to include 40 consecutive patients admitted to the general intensive care unit. The control group will receive nutritional support composed of a standard formula. The study group will receive nutritional support enriched with fish oil and anti-oxidants. The following variables will be assessed in all patients: demographics, severity of illness, assessment of bed sores. Blood tests will also be taken for the following: CD 8, CD 14, CD 18, CD 11a, CD49c, CD 49d. In addition, blood samples will be collected for TNF, IL-1b, IL-6, IL-8, and levels of C-reactive protein. Metabolic parameters such as resting energy expenditure, BMI, albumin, prealbumin, levels of zinc, relationship between omega 3 and omega 6. Theses test will be performed at time of ICU admission, days 7, 14 and 28 after admission.

The outcome: improved repair of pressure sores, together with improvement in objective parameters of immunity and inflammation.

Enrollment

40 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Critically ill patients in intensive care unit
  • Grade 2 pressure sores

Exclusion criteria

  • Immunosuppression with steroids or other agents
  • Active bleeding
  • Head trauma

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Study Group
Experimental group
Description:
Enteral Nutrition with Omega 3 (Eicosapentanoic acid, docosahexaenoic acid)
Treatment:
Dietary Supplement: Eicosapentanoic acid, docosahexaenoic acid
Control Group
No Intervention group
Description:
Patients in control group will receive nutritional support composed of a standard formula

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems